Browsing Category
Pharma Industry News
4757 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Novartis to expand oncology portfolio with acquisition of Mariana Oncology
Novartis has announced a significant move in the oncology sector with its agreement to acquire Mariana Oncology, a…
ONO Pharmaceutical to acquire Deciphera Pharmaceuticals in $2.4bn deal
ONO Pharmaceutical, Co., Ltd., has entered into a definitive agreement to acquire all outstanding shares of Deciphera Pharmaceuticals,…
Breaking: AstraZeneca confesses vaccine side effects! Covishield’s shocking health risks exposed!
In a dramatic turn of events, British pharmaceutical giant AstraZeneca has admitted that its COVID-19 vaccine, Covishield, can…
AstraZeneca’s Truqap, Faslodex combo recommended for EU approval for breast cancer treatment
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca’s Truqap (capivasertib) in…
AstraZeneca posts strong Q1 2024 results with significant revenue and EPS growth
AstraZeneca PLC has reported a notable performance in the first quarter of 2024, with total revenue reaching $12,679…
Pfizer secures FDA approval for Hemophilia B gene therapy BEQVEZ
Pfizer Inc. (NYSE: PFE) announced a significant breakthrough in hemophilia treatment with the U.S. Food and Drug Administration’s…
Amgen seeks European approval for teprotumumab in thyroid eye disease
Amgen (NASDAQ: AMGN), a global biotechnology leader, has announced its plans to submit a Marketing Authorization Application (MAA)…
Bristol Myers Squibb’s Opdivo set for EMA approval in urothelial carcinoma
Bristol Myers Squibb (NYSE: BMY), a global leader in biopharmaceuticals, has reached a significant milestone with the Committee…
Voydeya approved in EU for enhanced treatment of PNH with residual haemolytic anaemia
Voydeya (danicopan), a first-in-class oral Factor D inhibitor from Alexion, AstraZeneca Rare Disease, has received approval from the…
Dr. Reddy’s Laboratories announces voluntary recall of Sapropterin Dihydrochloride due to potency concerns
Dr. Reddy’s Laboratories Ltd., a prominent pharmaceutical company listed on multiple stock exchanges including BSE: 500124 and NYSE:…